1. Safety and immunogenicity of a synthetic carbohydrate conjugate vaccine against Shigella flexneri 2a in healthy adult volunteers: a phase 1, dose-escalating, single-blind, randomised, placebo-controlled study. Issue 4 (April 2021) Authors: Cohen, Dani; Atsmon, Jacob; Artaud, Cécile; Meron-Sudai, Shiri; Gougeon, Marie-Lise; Bialik, Anya; Goren, Sophy; Asato, Valeria; Ariel-Cohen, Ortal; Reizis, Arava; Dorman, Alexandra; Hoitink, Carla W G; Westdijk, Janny; Ashkenazi, Shai; Sansonetti, Philippe; Mulard, Laurence A; Phalipon, Armelle Journal: Lancet infectious diseases Issue: Volume 21:Issue 4(2021) Page Start: 546 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Serum IgG antibodies to Shigella lipopolysaccharide antigens – a correlate of protection against shigellosis. Issue 6 (3rd June 2019) Authors: Cohen, Dani; Meron-Sudai, Shiri; Bialik, Anya; Asato, Valeria; Goren, Sophy; Ariel-Cohen, Ortal; Reizis, Arava; Hochberg, Amit; Ashkenazi, Shai Journal: Human vaccines & immunotherapeutics Issue: Volume 15:Issue 6(2019) Page Start: 1401 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗